Is Beef Labeled "Raised Without Antibiotics" Actually Antibiotic-Free? A Disturbing Report Reveals, Maybe Not
One of the best tips for grocery shopping is to always read labels. From checking the expiration date to knowing what's in your food, it's best to be fully informed before you add anything to your shopping cart. But what about when the packaging is misleading? That's exactly what's happening right now with beef from some of the world's biggest suppliers.
According to a report by Sentient Media, last summer members of the U.S. Department of Agriculture's Food & Safety Inspection Service — a team within the USDA that makes sure food is safe and accurately labeled — discovered that antibiotics had been used by dozens of meat providers that sell meat labeled as 'antibiotic-free.' They found that 20 percent of the sample of meat labeled as antibiotic-free tested positive for antibiotics. The organization sent out letters to inform these companies, including Tyson, Cargill, and JBS, of their findings.
The USDA recommended that these meat producers take steps to figure out how the antibiotics were administered to the animals, and do whatever is necessary to make sure that beef products are no longer mislabeled. But that doesn't mean the companies are doing it. In fact, the USDA keeps approving labels from these same brands without requiring them to show proof of this claim.
Essentially there's a widespread mislabeling happening in grocery stores right now. When shoppers intend to purchase beef 'raised without antibiotics,' there's no guarantee that they're actually buying what they want. There's also a concern that overusing antibiotics causes bacteria to evolve more rapidly and become resistant to the drugs when they are actually medically necessary for humans and animals alike.
The USDA has updated its guidelines, recommending that companies use a third-party certification to confirm any animal-raising claims, but it's still just a recommendation that has yet to actually be enforced.
So, what's the average consumer to do? Right now it's hard to say exactly how to confirm that your meat is in fact free of antibiotics. The best you can do is stay aware of the ongoing mislabeled packaging, and try to shop locally and at farmers markets whenever possible.
Sign up for The Kitchn's Daily newsletter to receive our best recipes, posts, and shopping tips in your inbox.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Berkshire takes Kraft Heinz writedown, operating profit falls
(Reuters) -Warren Buffett's Berkshire Hathaway (BRK-A) (BRK-B) on Saturday wrote down part of its investment in Kraft Heinz (KHC), and reported a 4% decline in second-quarter operating profit as premiums from insurance underwriting fell. Berkshire also reported a 59% decline in net income, reflecting lower overall investment gains from its common stock holdings, as well as the Kraft Heinz writedown. Operating income totaled $11.16 billion, or about $7,760 per Class A share, compared with $11.6 billion a year earlier. Net income fell to $12.37 billion from $30.35 billion. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
12 minutes ago
- Yahoo
Willis Towers Watson Second Quarter 2025 Earnings: Beats Expectations
Willis Towers Watson (NASDAQ:WTW) Second Quarter 2025 Results Key Financial Results Revenue: US$2.26b (flat on 2Q 2024). Net income: US$331.0m (up 135% from 2Q 2024). Profit margin: 15% (up from 6.2% in 2Q 2024). EPS: US$3.34 (up from US$1.37 in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Willis Towers Watson Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) also surpassed analyst estimates by 38%. Looking ahead, revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's share price is broadly unchanged from a week ago. Risk Analysis Before you take the next step you should know about the 3 warning signs for Willis Towers Watson that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
ASGN Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
ASGN (NYSE:ASGN) Second Quarter 2025 Results Key Financial Results Revenue: US$1.02b (down 1.4% from 2Q 2024). Net income: US$29.3m (down 38% from 2Q 2024). Profit margin: 2.9% (down from 4.6% in 2Q 2024). EPS: US$0.67 (down from US$1.03 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period ASGN Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 4.8%. Looking ahead, revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the IT industry in the US. Performance of the American IT industry. The company's shares are down 11% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with ASGN. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio